发布时间：2026-04-23 16:00

Ad hoc announcement pursuant to Art. 53 LR





ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2026.


Strong start to the year delivering net sales of 1,473 million USD,predominantly driven by volume and complemented by positive price and mix effects, underscoring the continued execution of its unique, growth-driven integrated dermatology strategy.

Widespread net sales growth of 25.5% year-on-year at constant currency1,aligned with strong growth performance across geographies and product categories,including Injectable Aesthetics (+13.1%), Dermatological Skincare (+17.0%) and Therapeutic Dermatology (+71.3%).

Continued market outperformance,with broad-based growth momentum across the existing portfolio, complemented by differentiated launches and geographic expansion.

=*=*=*=*=*=
当前为第1/27页
下一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页